Zum Inhalt springen
News

Sumitomo Chemical selects Anaqua’s software to improve IP management

Business Management | Patente | Marken
Tags: Innovation Management, AQX Corporate

Japanese multinational company Sumitomo Chemical has selected Anaqua’s software and services to improve its IP management system.

By moving to Anaqua’s AQX platform, the chemical company aims to unify and enhance its global patent and trademark management processes.

Sumitomo Chemical, which manufactures petrochemicals, organic chemicals, IT-related chemicals, agrochemicals, and pharmaceuticals, selected Anaqua to replace its previous IP management system.

By leveraging Anaqua’s latest version of AQX software, the company will be able to streamline the entire IP management lifecycle starting from innovation creation and disclosure to patent annuity payment services.
The platform’s fully integrated software and services will support the company in unifying patent and trademark management processes across the world.

In addition, the company can improve its IP strategy with the help of the software’s real-time IP data analytics and forecasting capability.

Anaqua CEO Bob Romeo said: “We are thrilled to welcome another world-leading Japanese company to Anaqua’s client community and to provide integrated software and services that will enable them to manage their IP operations and strategy in a holistic fashion.

“Sumitomo Chemical has established itself as one of the most innovative companies in its field, and AQX will help IP portfolio managers at Sumitomo Chemical ensure they maximise the value of the organisation’s IP assets.”

Anaqua’s IP platform creates one intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations by uniting best practice workflows with big data analytics and tech-enabled services.

Established in 1914, Sumitomo Chemical operates through its segments Basic Chemicals, Petrochemicals and Plastics, Information Technology (IT)-related Chemicals, Health and Crop Sciences, Pharmaceuticals, and other segments.